UKMi Q&A xx
SIGN guidance recommends the addition of candesartan to an ACE inhibitor and a beta-blocker for patients heart failure with left ventricular systolic dysfunction who remain symptomatic.(8) At the time that this guidance was written in 2007, candesartan was the only ARB licensed to be used with an ACE inhibitor for heart failure and there have ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.